BioNTech SE (BNTX) Non-Current Debt (2018 - 2025)

BioNTech SE (BNTX) has 8 years of Non-Current Debt data on file, last reported at $409.4 million in Q4 2025.

• For the quarter ending Q4 2025, Non-Current Debt fell 73.46% year-over-year to $409.4 million; the trailing twelve-month figure through Dec 2025 stood at $409.4 million (down 73.46% YoY), and the FY2025 full-year result was $397.4 million, down 74.24% from the prior year.
• Non-Current Debt eased to $409.4 million in Q4 2025, from $698.4 million in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $1.6 billion in Q1 2022 to a low of $157.2 million in Q2 2024.
• A 5-year average of $610.3 million and a median of $456.6 million in 2023 frame the typical range for Non-Current Debt.
• Across the five-year window, Non-Current Debt jumped 394.44% in 2021 and tumbled 78.19% in 2023, its largest moves.
• Tracing BNTX's Non-Current Debt over 5 years: stood at $1.4 billion in 2021, then plunged by 41.18% to $801.0 million in 2022, then sank by 44.23% to $446.7 million in 2023, then surged by 245.27% to $1.5 billion in 2024, then slumped by 73.46% to $409.4 million in 2025.
• Business Quant data shows BNTX's Non-Current Debt at $409.4 million in Q4 2025, $698.4 million in Q3 2025, and $164.1 million in Q2 2025.